NMPA Approval

Metformin Hydrochloride and Empagliflozin Tablets (Ⅰ)

Approval Number

国药准字H20254143

Company浙江易泽达医药科技有限公司

Registration Date

May 13, 2025

Drug Information

Generic Name

二甲双胍恩格列净片(Ⅰ)

Dosage Form

片剂

Strength

每片含盐酸二甲双胍500mg与恩格列净5mg

Drug Type

化学药品

Registration Date

May 13, 2025

Company Information

Applicant Company

Company Name浙江易泽达医药科技有限公司

Company Address

浙江省杭州市临平区东湖街道天荷路42号4幢7层

Manufacturing Company

Company Name浙江赛默制药有限公司

Company Address

浙江省金华市婺城区汤溪镇永湖街788号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

二甲双胍恩格列净片(Ⅰ) - NMPA 批准文号 | MedPath